PillRx only · Tablet, Film Coated · Oral
Rizatriptan
Rizatriptan Benzoate
3 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US5 NDCs
3 active makers
3 active makers
UKComing
soon
soon
CAComing
soon
soon
AUComing
soon
soon
EUComing
soon
soon
US acquisition costNADAC · per unit
Average across 4 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
$0.352
Latest avg · Jul 22, 2026
-27%
Since Dec 17, 2025
3
Active US suppliers
96%
Top-2 supplier share*
Medicaid dispensing volumeSDUD · per quarter
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
90K
Rx · 2026 Q1
922K
Units dispensed
-3%
Rx vs. year ago
5
Quarters · since 2025 Q1
Who makes it3 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Macleods Pharmaceuticals Limited | unknown | 14 | SUPPLYING |
| Bryant Ranch Prepack | repackager | 8 | SUPPLYING |
| A-S Medication Solutions | unknown | 1 | SUPPLYING |
Regulatory & supply eventsFDA · US
Shortages, recalls, and registration changes attached to this drug concept.
- Oct 18, 2021RECALLRecall (Class III): Rizatriptan Benzoate Film Coated Tablets, 10 mg, packaged in a) 12 Tablets (2X6 Unit-Dose Tablets) Blister Packs, NDC 3…
Out-of-specification test results obtained in Organic Impurities test during analysis of controlled samples. — Recalling firm: MACLEODS PHARMA USA, INC — Nationwide within the United States